Sequana Medical, a Swiss medical device company founded in 2006, specializes in developing treatment solutions for fluid overload in liver disease, malignant ascites, and heart failure. Their flagship product, the Alfapump System, is an innovative solution for managing ascites, a fluid that accumulates in the abdominal cavity. With demonstrated safety, efficacy, and quality of life benefits, the Alfapump System automatically and continually removes ascites, offering a long-term management solution. Sequana Medical's proprietary approaches, alfapump® and DSR®, effectively remove excess fluid from patients' bodies, providing significant clinical and quality of life improvements while reducing healthcare costs. The company is listed on Euronext Brussels and headquartered in Ghent, Belgium. For more information, visit www.sequanamedical.com.